Middle East and Africa syndromic multiplex diagnostic market is projected to register a substantial CAGR in the forecast period of 2020 to 2027. The new market report contains data for historic year 2018, the base year of calculation is 2019 and the forecast period is 2020 to 2027.
Market Segmentation
Middle East and Africa Syndromic Multiplex Diagnostic Market, By Products and Services (Reagents & Consumables, Instruments & Accessories and Software & Services), Infection Type (Viral, Bacterial, Parasites, Fungal and Others), Disease (Respiratory Infections, Gastroenteritis, Sexually Transmitted Infections, Hepatitis, Tropical Fever, Meningitis, Childhood Infections, Immunosuppression and Eye Infections), Panels Type (Respiratory Panel, GI-Enteric Panel, Sexually Transmitted Disease Panel, Blood-Sepsis Panel, Meningitis Panel and Others), End User (Hospitals, Clinical Laboratories, Pharmaceutical & Biotechnology Companies, Research Institutes, Physician Office Lab's and Others), Country (South Africa and Rest of Middle East and Africa) Industry Trends and Forecast to 2027
Some of the major factors contributing to the growth of the Middle East and Africa syndromic multiplex diagnostic market are:
• Increasing demand for accurate and fast diagnostic results.
• Improving diagnosis seeking rate.
Market Players:
The key market players for Middle East and Africa syndromic multiplex diagnostic market are listed below:
• GenMark Diagnostics, Inc.
• QuantuMDx Group Ltd.
• BioFire Diagnostics (a subsidiary of bioMérieux SA)
• Bio-Rad Laboratories, Inc.
• Thermo Fisher Scientific Inc.
• Siemens Healthcare GmbH
• QIAGEN
• Hologic, Inc.
• F. Hoffmann-La Roche Ltd
• BD
• Danaher
• Curetis
• Abbott
• DiaSorin S.p.A.
• Bosch Healthcare Solutions GmbH (a subsidiary of Robert Bosch GmbH)
• Biocartis
• Luminex Corporation
• Seegene Inc.